Garcia-Beltran, C., Malpique, R., Andersen, M. S., Bas, F., Bassols, J., Darendeliler, F., . . . Ibanez, L. (2023). SPIOMET4HEALTH-efficacy, tolerability and safety of lifestyle intervention plus a fixed dose combination of spironolactone, pioglitazone and metformin (SPIOMET) for adolescent girls and young women with polycystic ovary syndrome: Study protocol for a multicentre, randomised, double-blind, placebo-controlled, four-arm, parallel-group, phase II clinical trial.
Citação norma ChicagoGarcia-Beltran, Cristina, et al. SPIOMET4HEALTH-efficacy, Tolerability and Safety of Lifestyle Intervention Plus a Fixed Dose Combination of Spironolactone, Pioglitazone and Metformin (SPIOMET) for Adolescent Girls and Young Women With Polycystic Ovary Syndrome: Study Protocol for a Multicentre, Randomised, Double-blind, Placebo-controlled, Four-arm, Parallel-group, Phase II Clinical Trial. 2023.
Citação norma MLAGarcia-Beltran, Cristina, et al. SPIOMET4HEALTH-efficacy, Tolerability and Safety of Lifestyle Intervention Plus a Fixed Dose Combination of Spironolactone, Pioglitazone and Metformin (SPIOMET) for Adolescent Girls and Young Women With Polycystic Ovary Syndrome: Study Protocol for a Multicentre, Randomised, Double-blind, Placebo-controlled, Four-arm, Parallel-group, Phase II Clinical Trial. 2023.